The cost, and that is confidential & was negotiated for a maximum of 300 million doses, is a little less than the $19.50 per shot the United States agreed to purchase a first shipment of hundred million doses of the identical vaccine, in line with what Reuters claimed in November.
The EU document dated Nov. 18 was circulated internally after the EU announced its supply offer with Pfizer and its German partner BioNTech on Nov. eleven.
The EU drug regulator is actually expected to determine on Monday on endorsement for the Pfizer vaccine following the photo was authorised in a number of countries, including Britain and the United States.
On Thursday Belgian state secretary on your budget Eva De Bleeker published on Twitter a dinner table with costs Belgium would shell out pharmaceutical companies for the COVID-19 vaccines of theirs. She retracted the piece of writing shortly after publishing.
In that dining room table the Pfizer vaccine was suggested as costing Belgium twelve euros ($14.6) per dose, top many to believe this was the entire price agreed with the EU.
Various other vaccines in the family table were furthermore shown with rates lower than prices disclosed by EU sources.
“There is , naturally, a complete fee and a price after delivery,” an EU official involved in talks with vaccine makers told Reuters when made to clarify the big difference between the EU and Belgian rates.
A spokesman for De Bleeker declined to comment on Monday, citing confidentiality needs, but pointed to what De Bleeker told the Belgian parliament previous week. In this public hearing, De Beeker said Belgium’s budgeted prices were still partial.
Under EU advance purchase deals for COVID 19 vaccines, the bloc agrees initial payments with business enterprises to secure doses before they are approved. After approvals, EU governments can pay the rest to purchase reserved doses.
The EU hasn’t revealed the initial transaction agreed with Pfizer.
However, it said in October which it paid aproximatelly one billion euros inside downpayments to AstraZeneca, Sanofi and Johnson & Johnson for their shots, with a further 1.45 billion euros budgeted for upfront payments to Pfizer BioNTech, Moderna and Curevac.
It’s since agreed supply deals with all 6 corporations and it is negotiating a seventh arrangement with Novavax.